Rare diseases
Investigational molecules
Locations
Robert-Koch-Str. 3, 34376 Immenhausen, Germany
Lungenfachklinik in Immenhausen, Germany specialises in clinical trials of conditions such as Non-small cell lung cancer, Anaplastic lymphoma kinase gene mutation, Bronchiectasis, Idiopathic pulmonary fibrosis, and other specialisations. This site conducts important research.
The Lungenfachklinik focuses on pulmonary fibrosis and related interstitial conditions, evaluating new therapies to slow disease progression in patients with a family history of lung scarring.
With two active trials led by three investigators, the site in Immenhausen, Germany, aims to improve outcomes for individuals suffering from familial pulmonary fibrosis and other interstitial lung diseases.
More sites in ImmenhausenGermany
Clinical trials currently enrolling participants at this site.
Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
GermanyA study of ABBV-706 and atezolizumab for patients with previously untreated extensive stage small cell lung cancer
GermanyA study to evaluate the effectiveness of BI 1015550 in people with lung abnormalities and a family history of pulmonary fibrosis
GermanyTesting Treprostinil Palmitil Inhalation Powder for Improving Exercise Ability in Patients with Pulmonary Hypertension Related to Interstitial Lung Disease
GermanyStudy on the Safety and Effectiveness of Taladegib for Patients with Idiopathic Pulmonary Fibrosis
GermanyStudy on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy
GermanyStudy of Alectinib and Platinum-Based Chemotherapy for Patients with Resected Stage Ib to IIIa ALK-Positive Non-Small Cell Lung Cancer
GermanyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
